Royal Bank of Canada’s DarioHealth DRIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3K | Buy |
448
+319
| +247% | +$3.33K | ﹤0.01% | 6574 |
|
|
2025
Q4 | $1K | Buy |
129
+104
| +416% | +$1.37K | ﹤0.01% | 6984 |
|
|
2025
Q3 | $0 | Hold |
25
| – | – | ﹤0.01% | 7204 |
|
|
2025
Q2 | $0 | Sell |
25
-9,194
| -100% | -$128K | ﹤0.01% | 7086 |
|
|
2025
Q1 | $113K | Buy |
9,219
+9,064
| +5,848% | +$128K | ﹤0.01% | 5135 |
|
|
2024
Q4 | $2K | Sell |
155
-2,975
| -95% | -$51.5K | ﹤0.01% | 6701 |
|
|
2024
Q3 | $71K | Buy |
3,130
+2,675
| +588% | +$54.2K | ﹤0.01% | 5535 |
|
|
2024
Q2 | $12K | Sell |
455
-6,192
| -93% | -$175K | ﹤0.01% | 6264 |
|
|
2024
Q1 | $204K | Buy |
6,647
+6,599
| +13,748% | +$250K | ﹤0.01% | 4671 |
|
|
2023
Q4 | $2K | Sell |
48
-135
| -74% | -$4.81K | ﹤0.01% | 6796 |
|
|
2023
Q3 | $12K | Buy |
183
+8
| +5% | +$539 | ﹤0.01% | 6351 |
|
|
2023
Q2 | $14K | Buy |
175
+109
| +165% | +$8.28K | ﹤0.01% | 6345 |
|
|
2023
Q1 | $5K | Buy |
66
+41
| +164% | +$4.03K | ﹤0.01% | 6558 |
|
|
2022
Q4 | $2K | Sell |
25
-5
| -17% | -$450 | ﹤0.01% | 6920 |
|
|
2022
Q3 | $2K | Hold |
30
| – | – | ﹤0.01% | 7003 |
|
|
2022
Q2 | $4K | Sell |
30
-41
| -58% | -$4.81K | ﹤0.01% | 6712 |
|
|
2022
Q1 | $9K | Sell |
71
-108
| -60% | -$17.9K | ﹤0.01% | 6988 |
|
|
2021
Q4 | $45K | Sell |
179
-1,473
| -89% | -$448K | ﹤0.01% | 6427 |
|
|
2021
Q3 | $451K | Sell |
1,652
-133
| -7% | -$38.4K | ﹤0.01% | 4452 |
|
|
2021
Q2 | $763K | Buy |
1,785
+37
| +2% | +$14.1K | ﹤0.01% | 3892 |
|
|
2021
Q1 | $673K | Sell |
1,748
-218
| -11% | -$98.2K | ﹤0.01% | 3925 |
|
|
2020
Q4 | $562K | Hold |
1,966
| – | – | ﹤0.01% | 4040 |
|
|
2020
Q3 | $660K | Buy |
+1,966
| New | +$532K | ﹤0.01% | 3618 |
|
|
2020
Q1 | – | Sell |
-1
| Closed | – | – | 6735 |
|
|
2019
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 6875 |
|
|
2019
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6780 |
|
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6931 |
|
|
2019
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 6871 |
|
|
2018
Q4 | $0 | Hold |
1
| – | – | ﹤0.01% | 6825 |
|
|
2018
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6771 |
|
|
2018
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 6343 |
|
|
2018
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 6191 |
|
|
2017
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 6373 |
|
|
2017
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 6615 |
|
|
2017
Q2 | $1K | Hold |
1
| – | – | ﹤0.01% | 6379 |
|
|
2017
Q1 | $1K | Hold |
1
| – | – | ﹤0.01% | 6505 |
|
|
2016
Q4 | $1K | Hold |
1
| – | – | ﹤0.01% | 6546 |
|
|
2016
Q3 | $1K | Hold |
1
| – | – | ﹤0.01% | 6270 |
|
|
2016
Q2 | $2K | Hold |
1
| – | – | ﹤0.01% | 6135 |
|
|
2016
Q1 | $2K | Buy |
+1
| New | +$1.55K | ﹤0.01% | 6119 |
|
Other funds holding DRIO
NCM
VCM
VFT
VGA
Royal Bank of Canada's DRIO Position: Q1 2026 in Review
Royal Bank of Canada increased its DarioHealth (DRIO) stake by 247% in Q1 2026, buying an estimated $3.33K and bringing the position to 448 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #6574.
Royal Bank of Canada first reported a position in DRIO in Q1 2016 and has held it in 39 quarters since. The position peaked at $763K in Q2 2021. 21 funds tracked by Wall St. Rank hold DRIO as of Q1 2026.
- Royal Bank of Canada held 448 shares of DarioHealth worth $3K as of Q1 2026.
- Royal Bank of Canada bought 319 DarioHealth shares in Q1 2026, an estimated $3.33K.
- DarioHealth made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6574 holding.
- Royal Bank of Canada first reported a position in DarioHealth in Q1 2016 and has held it in 39 quarters since.
- Royal Bank of Canada's DarioHealth position peaked at $763K in Q2 2021.
- 21 funds tracked by Wall St. Rank held DarioHealth as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.